← Leaderboards
Joshua A Beckman
Brigham And Women'S Hospital
$4,886,792
Attributed
$5,280,525
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,280,525 · 5
By mechanism
R01$3,981,538 · 1
T32$706,602 · 1
K23$499,608 · 1
R03$89,229 · 1
M01$3,548 · 1
Top collaborators
- Aaron W. Aday1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Michael Salvatore Conte$9,171,065
- Niteesh K Choudhry$10,267,534
- Alik Farber$2,704,970
- Daniel I Simon$14,441,938
- Matthew Thomas Menard$2,040,511
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDiabetes MellitusUltrasonographyHuman SubjectMetabolicBlood VesselsOxidative StressCardiovascular FunctionEventAntioxidantsPathway InteractionsArterial Fatty StreakAdjudicateAmputationAortaAntithrombin Iii-Protease ComplexAgonistClaudicationAcuteBlood Flow MeasurementBlood FlowBlood PlateletsAnkleBypass
Grant awards (14)
The Impact of Diabetes on Revascularization in BEST-CLI$787,467
R01 · FY2020 · HL
Training in Cardiovascular Research$175,755
T32 · FY2020 · HL · contact PI
The Impact of Diabetes on Revascularization in BEST-CLI$789,179
R01 · FY2019 · HL · contact PI
Training in Cardiovascular Research$530,847
T32 · FY2019 · HL · contact PI
The Impact of Diabetes on Revascularization in BEST-CLI$789,165
R01 · FY2018 · HL · contact PI
The Impact of Diabetes on Revascularization in BEST-CLI$793,319
R01 · FY2017 · HL · contact PI
The Impact of Diabetes on Revascularization in BEST-CLI$822,408
R01 · FY2016 · HL · contact PI
A pilot study of moderate hyperbilirubinemia in type 1 diabetes mellitus$89,229
R03 · FY2011 · DK · contact PI
THE ROLE OF MINERALOCORTICOID RECEPTORS IN VASCULAR FUNCTION$2,233
M01 · FY2005 · RR
Role of Mineralocorticoid Receptors in Vascular Function$1,315
M01 · FY2004 · RR
MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN DIABETICS$124,200
K23 · FY2003 · HL
MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN DIABETICS$120,744
K23 · FY2002 · HL
MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN DIABETICS$124,200
K23 · FY2001 · HL
MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN DIABETICS$130,464
K23 · FY2000 · HL